US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

The Health Care Select Sector SPDR Premium Income Fund

25.71

+0.01000.04%

Post-market: 25.710.00000.00%19:30 EDT

Volume:13.23K

Turnover:339.91K

Market Cap:27.00M

PE:- -

High:25.76

Open:25.70

Low:25.63

Close:25.70

52wk High:27.35

52wk Low:24.20

Shares:1.05M

Float Shares:1.05M

Volume Ratio:0.15

T/O Rate:1.26%

Dividend:3.29

Dividend Rate:12.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders

Lucid Diagnostics advances Medicare reimbursement and coding infrastructure

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Hong Kong Stock Flash | JW (Cayman) Therapeutics (02126) Surges Over 20% Intraday as CAR-T Therapy Makes Historic Debut in Basic Medical Insurance Negotiations

Weight-Loss Drug Giant Sheds 13,000 Positions

Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers

Health Advisory: Avoid Misusing Weight-Loss Medications, Prioritize Evaluation Before Treatment

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal

India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates

China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks

Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure

Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development

AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit

Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination

Cresud to Pay Fourth Interest Installment on Series XLVI Notes on July 20, 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/XLVI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLVI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLVI\",,,,,undefined,":{"symbol":"XLVI","market":"US","secType":"STK","nameCN":"The Health Care Select Sector SPDR Premium Income Fund","latestPrice":25.71,"timestamp":1790971200000,"preClose":25.7,"halted":0,"volume":13229,"hourTrading":{"tag":"盘后","latestPrice":25.71,"preClose":25.71,"latestTime":"19:30 EDT","volume":29,"amount":754.83,"timestamp":1790983803632,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0003891050583658196,"floatShares":1050000,"shares":1050000,"eps":0,"marketStatus":"Market Closed","change":0.01,"latestTime":"10-02 16:00:00 EDT","open":25.7,"high":25.755,"low":25.63,"amount":339908.809922,"amplitude":0.004864,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":25.7,"sharesOutstanding":490000,"nav":25.734139,"aum":27792870.13,"dividendRate":0.127849,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.71,"preClose":25.71,"latestTime":"19:30 EDT","volume":29,"amount":754.83,"timestamp":1790983803632,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.14512770664541455},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLVI\",,,,,undefined,":{"symbol":"XLVI","floatShares":1050000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.14512770664541455,"shares":1050000,"dividePrice":3.287,"high":25.755,"amplitude":0.004864,"preClose":25.7,"low":25.63,"week52Low":24.2,"pbRate":"--","week52High":27.35,"institutionHeld":0,"latestPrice":25.71,"eps":0,"divideRate":0.127849,"volume":13229,"delay":0,"ttmEps":0,"open":25.7,"prevYearClose":26.4307,"prevWeekClose":26.4833,"prevMonthClose":26.37,"prevQuarterClose":26.37,"fiveDayClose":26.4833,"twentyDayClose":26.87,"sixtyDayClose":26.3198},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLVI\",params:#limit:5,,,undefined,":[{"date":"2026-10-01","symbol":"XLVI","amount":0.313779,"announcedDate":"2026-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-10-01","defaultRemindTime":1790861400000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-05","payableDate":"2026-10-01","currency":"USD","dateTimestamp":1790827200000,"payDate":"2026-10-05"},{"date":"2026-09-01","symbol":"XLVI","amount":0.284682,"announcedDate":"2026-08-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-01","defaultRemindTime":1788269400000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-03","payableDate":"2026-09-01","currency":"USD","dateTimestamp":1788235200000,"payDate":"2026-09-03"},{"date":"2026-08-03","symbol":"XLVI","amount":0.220362,"announcedDate":"2026-07-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-03","defaultRemindTime":1785763800000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-05","payableDate":"2026-08-03","currency":"USD","dateTimestamp":1785729600000,"payDate":"2026-08-05"},{"date":"2026-07-01","symbol":"XLVI","amount":0.265104,"announcedDate":"2026-06-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-06","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-06"},{"date":"2026-06-01","symbol":"XLVI","amount":0.20398,"announcedDate":"2026-05-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-01","defaultRemindTime":1780320600000,"name":"The Health Care Select Sector SPDR Premium Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-03","payableDate":"2026-06-01","currency":"USD","dateTimestamp":1780286400000,"payDate":"2026-06-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLVI\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-02","recordDate":"2025-09-02","paymentDate":"2025-09-05","value":0.373503,"currency":"USD"},{"executeDate":"2025-10-01","recordDate":"2025-10-01","paymentDate":"2025-10-03","value":0.293409,"currency":"USD"},{"executeDate":"2025-11-03","recordDate":"2025-11-03","paymentDate":"2025-11-05","value":0.244969,"currency":"USD"},{"executeDate":"2025-12-01","recordDate":"2025-12-01","paymentDate":"2025-12-03","value":0.273076,"currency":"USD"},{"executeDate":"2025-12-29","recordDate":"2025-12-29","paymentDate":"2025-12-31","value":0.329285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLVI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLVI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1176833437","title":"2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders","url":"https://stock-news.laohu8.com/highlight/detail?id=1176833437","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176833437?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:00","pubTimestamp":1790755226,"startTime":"0","endTime":"0","summary":"The 2026 Nobel Prize laureates will be announced successively from October 5 to 12. In order to understand the list of hot candidates, The Scientist published scientists' predictions for the 2026...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUH","LLII","THNR","NVOC","ELIS","OZEM","LLYX","NVOX","XLVI","FHLC","PJP","PINK","IYH","JDOC","NVOH","CURE","MEDI","NBDS","ELIL","RSPH","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147769","title":"Lucid Diagnostics advances Medicare reimbursement and coding infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147769","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147769?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:29","pubTimestamp":1790083753,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics ( ($LUCD) ) has provided an update. On September 22, 2026, Lucid Diagnostics announced key advances in payment, billing and codin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","TMED","FXH","BK4099","IHF","IE00B775SV38.USD","LU1267930490.SGD","LU0868494617.USD","LU1084165304.USD","MHIP","REZ","SG9999014013.SGD","BK4588","LCIZ","BK4551","IHI","BK4585","LU0708994859.HKD","XLVI","LCDL","XLVX","MEDI","LUCD","IE00B3S45H60.SGD","AGNG","HTEC","LCID","LU0310800379.SGD","IEHS","IYH","HCA","SG9999014039.USD","TRUH","CURE","FHLC","MHIG","PTH","BK4082","RSPH","JHMH","RXD","PSCH","XHE","LNGR","LU1150488135.SGD","PINK","DVXV","LU0310799852.SGD","LU0433182093.SGD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174429461","title":"Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1174429461","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174429461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082018,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX.US) saw its shares spike nearly 50% in Tuesday's premarket trading after the biotech announced that its experimental obesity drug, VK2735, helped patients maintain most of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","THNR","BK4007","NBDS","PINK","BK4139","BK4599","TRUH","BK4585","IYH","RSPH","FXH","OZEM","FHLC","NVOH","PJP","VKTX","LENZ","MEDI","BK4539","CURE","XLVI","NVOX","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106140436","title":"Hong Kong Stock Flash | JW (Cayman) Therapeutics (02126) Surges Over 20% Intraday as CAR-T Therapy Makes Historic Debut in Basic Medical Insurance Negotiations","url":"https://stock-news.laohu8.com/highlight/detail?id=1106140436","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106140436?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:58","pubTimestamp":1790060301,"startTime":"0","endTime":"0","summary":"JW (Cayman) Therapeutics (02126) saw its share price climb more than 20% during Tuesday's trading session. As of the latest update, the stock was up 17.72%, trading at HKD 2.79, with a transaction...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BMED","APXH","BK4585","02126","KCAI","XLVI","BK4588","VXUS","BK1161","PBPH","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194733778","title":"Weight-Loss Drug Giant Sheds 13,000 Positions","url":"https://stock-news.laohu8.com/highlight/detail?id=1194733778","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194733778?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:30","pubTimestamp":1790004634,"startTime":"0","endTime":"0","summary":"After announcing plans last September to cut 9,000 jobs, Novo Nordisk disclosed the final headcount reduction figures at its Capital Markets Day held in London on September 21.Novo Nordisk stated...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","FXH","IYH","NBDS","NVOH","XLVI","PINK","PJP","NVOC","THNR","CURE","RSPH","NVOX","MEDI","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181721651","title":"Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers","url":"https://stock-news.laohu8.com/highlight/detail?id=1181721651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181721651?lang=en_us&edition=fundamental","pubTime":"2026-09-21 14:01","pubTimestamp":1789970464,"startTime":"0","endTime":"0","summary":"A bullish MACD crossover signal has emerged, indicating strong upward momentum for select pharmaceutical stocks. This technical indicator, often seen as a precursor to sustained gains, has caught the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","SBIO","GDOC","BK4585","BK4588","BK1161","BBP","LFSC","MEDX","GSKH","APXH","IBBQ","BK1574","159992","BIOY","06978","XLVI","LNGR","IBB","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195583160","title":"Health Advisory: Avoid Misusing Weight-Loss Medications, Prioritize Evaluation Before Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1195583160","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195583160?lang=en_us&edition=fundamental","pubTime":"2026-09-19 16:50","pubTimestamp":1789807829,"startTime":"0","endTime":"0","summary":"This is a public service announcement from the local market regulatory authority. All works published on this website that indicate their source or author as relevant government bodies or departments...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURE","MEDI","NBDS","XLVI","FHLC","TRUH","PJP","PINK","NVOX","THNR","NVOC","IYH","NVOH","RSPH","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURE","PINK","RSPH","NBDS","NVOX","FHLC","IYH","NVOH","XLVI","PJP","BGIA","THNR","TRUH","FXH","NVOC","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131442769","title":"Eli Lilly Expands Beyond Weight-Loss Dominance With Potential $2.88B Autoimmune Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1131442769","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131442769?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:22","pubTimestamp":1788182577,"startTime":"0","endTime":"0","summary":"Eli Lilly and Co (NYSE: LLY) is set to acquire Merida Biosciences Inc. for up to $2.88 billion in cash, marking a strategic push into autoimmune and allergic disease treatments as the pharma giant...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURE","IYH","PINK","NBDS","FXH","NVOX","PJP","FHLC","NVOH","NVOC","XLVI","MEDI","TRUH","RSPH","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128151773","title":"India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=1128151773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128151773?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:56","pubTimestamp":1787954186,"startTime":"0","endTime":"0","summary":"India's weight-loss drug market is delivering a sobering lesson to the global pharmaceutical industry about market expectations. Despite large-scale generic production of GLP-1 medications and prices...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURE","ELIS","NBDS","FHLC","LLII","IYH","UUP","UDN","NVOX","LLYX","MEDI","THNR","PINK","ELIL","FXH","PJP","NVOC","MNDmain","XLVI","OZEM","JDOC","NVOH","TRUH","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108000527","title":"China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=1108000527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108000527?lang=en_us&edition=fundamental","pubTime":"2026-08-14 15:38","pubTimestamp":1786693102,"startTime":"0","endTime":"0","summary":"China Galaxy Securities has released a research report stating that laboratory animals are a fundamental necessity for innovative drug research and development, with deep industry barriers. Two key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","IBB","GDOC","BK1147","LFSC","SBIO","601881","WRND","06881","GSKH","XLVI","APXH","BIOY","PBE","BK0276","161027","BK1564","BK4588","BBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142463773","title":"Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=1142463773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142463773?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:10","pubTimestamp":1786543834,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) issued a statement on August 12, revealing that its stock price has experienced an unusual surge, with cumulative closing price gains exceeding...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600721","GSKH","APXH","PBE","BK4588","LFSC","WRND","BIOY","BK4585","SBIO","BK0102","BK0216","GDOC","IBB","XLVI","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174341976","title":"Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1174341976","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174341976?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:08","pubTimestamp":1786450094,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) has issued a stock trading risk warning announcement, stating that it is a CRO enterprise primarily focused on the research and development of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","600721","WRND","SBIO","BK0216","BK4588","BIOY","GSKH","XLVI","BK0102","GDOC","PBE","APXH","IBB","BBP","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118729610","title":"AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1118729610","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118729610?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:12","pubTimestamp":1786428745,"startTime":"0","endTime":"0","summary":"A research report from Orient Securities Company Limited highlights that as global regulatory shifts accelerate, the large-scale application of AI in pharmaceuticals is rapidly advancing. It has...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTHR","PBE","BK0276","600958","IBB","03958","BK4588","XLVI","CHAT","GDOC","BK0183","BK4585","AIPO","BBP","BK0028","BIOY","BK1564","GSKH","WRND","BK1147","BK0188","QTOC","APXH","AGIX","BK0012","ARTY","SBIO","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184959126","title":"Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination","url":"https://stock-news.laohu8.com/highlight/detail?id=1184959126","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184959126?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:21","pubTimestamp":1785878467,"startTime":"0","endTime":"0","summary":"Amgen reported its second-quarter earnings after the U.S. stock market close on Tuesday, with robust drug sales boosting profits, leading the company to raise its full-year outlook. However, it also...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE00B4R5TH58.HKD","IBBQ","BK4566","IE00BFTCPJ56.SGD","BK4599","LU2242652126.USD","NBDS","PINK","IE00BJJMRZ35.SGD","LU2468319806.SGD","BK4534","MEDI","LU0289739699.SGD","IE00BJT1NW94.SGD","BIB","LU0320765992.SGD","AMGN","LU0122379950.USD","RSPH","LU0868494617.USD","FHLC","IE0009355771.USD","THNR","PJP","BK4581","TRUH","BK4533","XLVI","IBB","TBXU","LU1983299246.USD","BK4585","LU2242646821.SGD","BK4139","CURE","LU2112291526.USD","BK4588","LU0889565916.HKD","LU0109394709.USD","LU1061106388.HKD","LU1571399168.USD","IYH","LU0058720904.USD","LU2089984988.USD","NVOC","BBH","SG9999001440.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU1057294990.SGD","FXH","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651815554","title":"Cresud to Pay Fourth Interest Installment on Series XLVI Notes on July 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651815554","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651815554?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:30","pubTimestamp":1784061055,"startTime":"0","endTime":"0","summary":"Cresud Sociedad ( ($CRESY) ) has provided an update. Cresud S.A.C.I.F. y A., the Argentine agribusiness and real estate group, has announced detail...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cresud-to-pay-fourth-interest-installment-on-series-xlvi-notes-on-july-20-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cresud-to-pay-fourth-interest-installment-on-series-xlvi-notes-on-july-20-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVI","REET"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}